OncoSec Medical Inc Propriété du management
Quel est le Propriété du management de OncoSec Medical Inc?
Le Propriété du management de OncoSec Medical Inc est 55.94%
Quelle est la définition de Propriété du management?
La propriété d'un initié est calculée en divisant le nombre total d'actions possédées par des initiés (actionnaires détenant plus de 5% de la société ou un dirigeant ou un administrateur de la société) par le nombre total d'actions en circulation.
A high value of insider ownership means that those working for the company have a large stake in the success of the company. This is sometimes seen as a sign that those running the company will work hard to ensure its success or believe the company's stock price will rise.
A change in insider ownership may come from exercise of option, stock grant and buying or selling of company shares. A purchase of company share signifies a confidence in the company's future performance by people who know the company best. Therefore, Net Insider buying is also an important indicator for investors.
Propriété du management des entreprises dans Health Care secteur sur NASDAQ par rapport à OncoSec Medical Inc
Que fait OncoSec Medical Inc?
oncosec is a san diego-based biotechnology company pioneering new technologies to stimulate the body’s immune system to target and attack cancer. through our proprietary technology, we hope to deliver safer and more effective cancer treatments that can provide long-term benefits for patients. our technology, immunopulse™, is designed to enhance the local delivery and uptake of dna-based immune-targeting agents, such as il-12. clinical trials of immunopulse™ il-12 demonstrated a favorable safety profile and evidence of anti-tumor activity in the treatment of various skin cancers as well as the potential to initiate a systemic immune response. our lead program, immunopulse™ il-12, is currently in phase ii development for several indications, including metastatic melanoma, squamous cell carcinoma of the head and neck, and triple-negative breast cancer. to date, study results have laid the groundwork for the expansion into new dna-encoded therapeutic candidates and tumor indications. we ar
Entreprises avec propriété du management similaire à OncoSec Medical Inc
- Axway Software SA a Propriété du management de 55.92%
- Euroseas Ltd a Propriété du management de 55.92%
- Helios a Propriété du management de 55.93%
- Hawkins Cookers a Propriété du management de 55.93%
- Pro Medicus a Propriété du management de 55.94%
- Grown Up Investment a Propriété du management de 55.94%
- OncoSec Medical Inc a Propriété du management de 55.94%
- Man Yue Technology a Propriété du management de 55.94%
- Cue Resources a Propriété du management de 55.95%
- Zeotech a Propriété du management de 55.95%
- Tofutti Brands a Propriété du management de 55.95%
- Elemental Royalties Ltd a Propriété du management de 55.96%
- Elemental Royalties Ltd a Propriété du management de 55.96%